A High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Quantitation of Nitrogen-Containing Intracellular Metabolites  by Lu, Wenyun et al.
A High-Performance Liquid
Chromatography-Tandem Mass Spectrometry
Method for Quantitation of Nitrogen-
Containing Intracellular Metabolites
Wenyun Lu, Elizabeth Kimball, and Joshua D. Rabinowitz
Lewis-Sigler Institute for Integrative Genomics and Department of Chemistry, Princeton University,
Princeton, New Jersey, USA
A comprehensive method of quantifying intracellular metabolite concentrations would be a
valuable addition to the arsenal of tools for holistic biochemical studies. Here, we describe a
step toward the development of such method: a quantitative assay for 90 nitrogen-containing
cellular metabolites. The assay involves reverse-phase high-performance liquid chromatogra-
phy separation followed by electrospray ionization and detection of the resulting ions using
triple-quadrupole mass spectrometry in selected reaction monitoring mode. For 79 of the 90
metabolites, the assay is linear with a limit of detection of 10 ng/mL or less. Using this method,
36 metabolites can be reliably detected in extracts of the bacterium Salmonella enterica, with the
identity of each metabolite confirmed by the presence, on growing of the bacteria in
13C-glucose, of a peak corresponding to the isotope-labeled form of the compound. Quantita-
tion in biological samples is performed by mixing unlabeled test cell extract with 13C-labeled
standard extract, and determining the 12C/13C-ratio for each metabolite. Using this approach,
the metabolomes of growing (exponential phase) and carbon-starved (stationary phase)
bacteria were compared, revealing 16 metabolites that are significantly down-regulated and
five metabolites that are significantly up-regulated, in stationary phase. (J Am Soc Mass
Spectrom 2006, 17, 37–50) © 2005 American Society for Mass SpectrometryThe chemical reaction network of cellular metabo-lism, which produces complex biomolecules fromsimple nutrients, is highly conserved in living
systems. The structure of the metabolic reaction net-
work has been mapped in substantial detail using
organic chemistry, biochemistry, and genetic ap-
proaches, with modern metabolic maps of certain well-
studied model organisms, such as enteric bacteria and
bakers yeast, including some 500 different water-solu-
ble compounds interconverting using appropriately 700
chemical reactions. Recent data from the sequencing of
the complete genomes of these organisms suggest that
the majority of all major, nonlipid metabolic transfor-
mations required for their survival and growth are
captured in current maps [1–7]. Thus, for certain model
organisms, there is now an opportunity to shift from
metabolite structure identification and qualitative de-
scription of reaction pathways to quantitative analysis
of the rates and regulation of cellular metabolic reac-
tions.
A major barrier to quantitative understanding of the
cellular metabolic network has been the lack of appro-
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Although assays, often enzyme-based, for determining
the concentrations of certain metabolites on a one-by-
one basis have been available for some time [8–10],
methods for simultaneous quantitation of numerous
metabolites are only now being developed for the first
time. A major challenge in the development of these
assays is the low abundance of most intracellular me-
tabolites. In total, metabolites comprise only approxi-
mately 3% of cell dry weight of enteric bacteria [11]. Of
this amount, a large preponderance is in the form of a
few prevalent species, for example, in enteric bacteria,
glutamate [12–15], with most metabolites present in
only very small quantities. Thus, many metabolites are
proverbial “needles” in the “haystack” of more preva-
lent metabolites and other biomolecules.
Previous efforts to measure multiple metabolites in
parallel have applied a variety of approaches, including
thin-layer chromatography (TLC) [13, 14], high-perfor-
mance liquid chromatography (HPLC) with detection
based on absorption or emission of light [12, 15],
nuclear magnetic resonance spectroscopy [16, 17], and
chromatography coupled to mass spectrometry [18–23].
Approaches not using mass spectrometry detection,
although able to produce characteristic signal patterns
for metabolite mixtures, suffer from both low sensitivity
(unless radioactive labeling is used) and low specificity
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38 LU ET AL. J Am Soc Mass Spectrom 2006, 17, 37–50(difficulty relating observed peaks to particular molec-
ular entities). For example, a recent study of intracellu-
lar metabolites by two-dimensional TLC, although im-
pressively resolving up to 99 spots, was able to quantify
only 23 of these spots and to associate only 13 of these
with particular chemical species [14]. Mass spectrome-
try, in contrast, has the potential to detect metabolites
with high sensitivity in the absence of radioactive
labeling and to distinguish even closely related species
based on molecular weight.
To date, the bulk of metabolite quantitation by mass
spectrometry has focused on drug metabolites or serum
biomarkers [19, 24–26], not intracellular metabolites.
For biomarker measurement, a common approach is to
couple HPLC to a mass spectrometer with high mass
accuracy, such as a time-of-flight instrument. This ap-
proach has enabled approximate quantitation of ap-
proximately 1500 molecular ions from human serum, a
remarkable achievement [19]. Most of these molecular
ions were not, however, associated specifically with
known metabolites, and the ability of this technique to
detect intracellular metabolites was not reported. For
quantitation of known metabolites (usually of drugs)
from complex matrices such as serum, a sensitive
approach is to couple HPLC to a triple-quadrupole
mass spectrometer operating in selected reaction mon-
itoring (SRM) mode. Accurate quantitation is ensured
by incorporation of isotope-labeled internal standard of
the metabolite of interest in the analysis mixture. This
approach seems well suited to measurement of intra-
cellular metabolites, where the molecular entities of
interest are known and sensitivity is of paramount
importance. Isotope-labeled internal standard (for a test
culture grown in nutrients of the experimenter’s choos-
ing) can be generated by growing a control culture of
cells in isotope-labeled nutrient (e.g., 13C-glucose) [21].
Alternatively, to enable absolute quantitation of metab-
olites, an extract of test cells grown in isotope-labeled
glucose can be spiked with commercially available,
unlabeled, purified metabolites as the internal control.
Heijnen and colleagues recently have applied this tech-
nique to measure 11 different intracellular metabolites
involved in central carbon metabolism [23]. The ability
to scale up this technique, however, to measure a much
larger number of metabolites, has been unclear, given
the historical tendency to apply SRM scanning to study
only a few analytes at once. To investigate this possi-
bility, we attempted to develop a method that enables
simultaneous measurement of numerous nitrogen-con-
taining metabolites, because nitrogen-containing com-
pounds constitute a majority of the known metabolites
of enteric bacteria included in current metabolic maps
[4] and generally ionize well by electrospray in positive
ion mode. Here, we report the development of a
method that enables simultaneous measurement of 90
such compounds, with sufficient sensitivity to quan-
tify reliably 36 of these metabolites from bacterial
cells.Experimental
Chemicals and Reagents
HPLC-grade solvents (water, methanol, and acetoni-
trile; OmniSolv, EMD Chemical) were obtained through
VWR International (West Chester, PA). Formic acid
(88%) was purchased from Fisher Scientific (Pittsburgh,
PA). All the 90 purified metabolite standards (see Table
1), as well as reserpine and all media components (see
section Bacterial Strain and Culture Conditions), were
obtained through Sigma-Aldrich (St. Louis, MO) and
are 98% or more pure according to the manufacturer.
13C-d-glucose (99%) was obtained from Cambridge
Isotope Laboratories (Andover, MA).
For each purified metabolite, stock solution (100
g/mL) was prepared in 50:50 methanol/water with
0.1% formic acid and stored at 80 °C. Fresh samples
were prepared every 3 months or more often as needed.
For liquid chromatography-tandem mass spectrometry
(LC-MS/MS) studies, working solutions at 1 g/mL, as
well as mixed compound solutions at various concen-
trations, were prepared as needed.
Instrumentation
Mass spectrometric analyses were performed on a
Finnigan TSQ Quantum Ultra triple-quadrupole mass
spectrometer (Thermo Electron Corporation, San Jose,
CA), equipped with electrospray ionization (ESI) source
operated in positive-ion mode. The mass spectrometer
syringe pump was used to infuse purified compounds
for initial studies of MS/MS fragmentation and, subse-
quently, LC-MS/MS was performed using a LC-10A
HPLC system (Shimadzu, Columbia, MD) coupled to
the mass spectrometer. The mass spectrometer was
controlled by the Quantum Tune Master software
(Thermo Electron Corporation, version 1.2). Nitrogen
was used as sheath gas and auxiliary gas and argon was
used as the collision gas. The mass spectrometer was
initially calibrated and ionization was optimized using
the polytyrosine-1,3,6 standards (Thermo Electron Cor-
poration), as well as metabolite standards, with the
optimized ionization conditions for the selected LC
solvent and flow rate (water/methanol at 100 L/min)
being spray voltage 3200 V, sheath gas 30 psi, auxiliary
gas 10 psi, and capillary temperature 325 °C. In the SRM
mode for MS/MS analysis, collision gas pressure was
1.5 mtorr with a scan time for each SRM transition of
0.1 s and a scan width of 1 m/z. The instrument control,
data acquisition, and data analysis were performed
by the Xcalibar software (Thermo Electron Corpora-
tion, version 1.4 SR1), which also controlled the
chromatography system. The LC parameters were as
follows: autosampler temperature, 4 °C; injection
volume, 10 L; column temperature, 15 °C; and flow
rate, 100 L/min.
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Compounda
Neutral
formula
Parent
mass
Collision
energy
(eV)
Preferred
productb
Mass of
preferred
product
Masses of
other major
productsc
RTd
(minutes)
LODe
(ng/mL)
Urea CH4N2O 61 20 CH2NO
 44 N/A 7.7 100
Glycine C2H5NO2 76 16 CH4N
 30 43, 44 6.5 10
Putrescine C4H12N2 89 11 C4H10N
 72 30 5.0 0.5
Alanine C3H7NO2 90 11 C2H6N
 44 N/A 6.7 10
Betaine aldehyde C5H11NO 102 17 C3H9N
 59 42, 58 7.0, 8.0 10
Choline C5H13NO 104 19 C3H10N
 60 42, 45, 58 8.0 1
Serine C3H7NO3 106 13 C2H6NO
 60 42, 70 6.6 5
Cytosine C4H5N3O 112 17 C4H3N2O
 95 52, 69 6.4 10
Uracil C4H4N2O2 113 23 C3H4NO
 70 40, 43, 96 12.0 50
Proline C5H9NO2 116 11 C4H8N
 70 68 7.8 5
Valine C5H11NO2 118 11 C4H7
 55 72 7.8 5
Threonine C4H9NO3 120 30 C3H5O
 57 56, 74, 102 6.8 10
Homoserine C4H9NO3 120 30 C2H6N
 44 56, 74, 102 6.8 10
Cysteine C3H7NO2S 122 27 C2H3S
 59 76, 87 7.2 5
Nicotinamide C6H6N2O 123 20 C5H6N
 80 53, 78 12.5 10
Nicotinic acid C6H5NO2 124 20 C5H6N
 80 53, 78 11.6 10
Taurine C2H7NO3S 126 10 C2H6NO2S
 108 44 6.9 50
Thymine C5H6N2O2 127 17 C5H4NO2
 110 54, 56, 84 22.7 10
Agmatine C5H14N4 131 16 C4H10N
 72 60, 97, 114 5.3 1
Isoleucine/leucine C6H13NO2 132 11 C5H12N
 86 44, 69 8.6, 11.0 10
Ornithine C5H12N2O2 133 12 C4H8N
 70 116 5.6 5
Asparagine C4H8N2O3 133 17 C2H4NO2
 74 70, 87 6.9 5
Aspartic acid C4H7NO4 134 15 C2H4NO2
 74 70, 88 6.8 5
Adenine C5H5N5 136 24 C5H3N4
 119 65, 92, 94 7.8 0.5
Hypoxanthine C5H4N4O 137 19 C4H4N3O
 110 94, 119 17.0 10
p-Aminobenzoic acid C7H7NO2 138 24 C6H5
 77 65, 92, 120 28.8 10
Anthranilic acid C7H7NO2 138 20 C6H6N
 92 65, 120 35.0 0.5
Histidinol C6H11N3O 142 18 C5H7N2
 95 81, 124 5.1 5
Spermidine C7H19N3 146 13 C7H14N
 112 58, 72, 84 4.9 50
Lysine C6H14N2O2 147 15 C5H10N
 84 130 5.5 1
Glutamine C5H10N2O3 147 15 C4H6NO
 84 41, 56, 130 6.8 0.1
Glutamate C5H9NO4 148 15 C4H6NO
 84 41, 56, 102 6.8 1
O-acetyl-L-serine C5H9NO4 148 12 C3H8NO3
 106 42, 60, 88 7.4 5
Methionine C5H11NO2S 150 10 C5H9O2S
 133 56, 61, 104 7.9 10
Guanine C5H5N5O 152 16 C5H3N4O
 135 110 7.8 10
Xanthine C5H4N4O2 153 16 C4H4N3O
 110 81, 136 22.0 10
Histidine C6H9N3O2 156 12 C5H8N3
 110 83, 93 5.7 5
Orotic acid C5H4N2O4 157 25 C3H2NO
 68 70, 79, 111 16.0 10
Allantoin C4H6N4O3 159 11 C3H3N2O2
 99 61, 73, 81 7.7 500
Carnitine C7H15NO3 162 18 C4H7O3
 103 58, 60, 85 7.2 0.5
Phenylalanine C9H11NO2 166 28 C8H7
 103 77, 91, 120 22 5
Pyridoxine C8H11NO3 170 22 C8H8NO
 134 152 7.9 0.1
Arginine C6H14N4O2 175 14 CH6N3
 60 70, 116, 130 5.8 1
N-acetyl-ornithine C7H14N2O3 175 14 C5H9NO2
 115 70, 158 6.4 5
Citrulline C6H13N3O3 176 12 C6H11N2O3
 159 70, 113 7.1 5
Allantoic acid C4H8N4O4 177 16 CH5N2O
 61 74, 117 7.8, 8.5 10
Glucosamine C6H13NO5 180 10 C6H12NO4
 162 72, 84 5.7 10
Tyrosine C9H11NO3 182 14 C8H10NO
 136 77, 91, 119 12.8, 15.0 10
Homocysteic acid C4H9NO5S 184 13 C3H8NO3S
 138 56 8.8 10
3-Phospho-serine C3H8NO6P 186 10 C3H6NO2
 88 42, 70 8.7 5
N-acetyl-glutamine C7H12N2O4 189 15 C5H8NO3
 130 56, 84 10.0, 11.0 10
Tryptophan C11H12N2O2 205 16 C9H8NO
 146 91, 115, 118 29.0 1
Pantothenic acid C9H17NO5 220 20 C3H8NO2
 90 124, 202 27.2 1
Cystathionine C7H14N2O4S 223 11 C4H8NO2S
 134 88 6.5 1
Deoxyuridine C9H12N2O5 229 11 C4H5N2O2
 113 96 22.0 50
Thymidine C10H14N2O5 243 16 C5H7N2O
 127 109, 110 27.0 5
Cytidine C9H13N3O5 244 12 C4H6N3O
 112 95 7.5 0.5
Biotin C10H16N2O3S 245 18 C10H15N2O2S
 227 97 34.0 5
Uridine C9H12N2O6 245 15 C4H5N2O2
 113 70, 96 15.0, 16.5 10
Deoxyadenosine C10H13N5O3 252 20 C5H6N5
 136 119 24.9 1
Deoxyinosine C10H12N4O4 253 12 C5H5N4O
 137 119 26.2 5(Continued)
noise
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For the purpose of SRM analysis, it is necessary to deter-
mine the fragmentation products of each metabolite par-
ent (precursor) ion. A 1-g/mL working solution of each
metabolite was infused into the mass spectrometer at a
flow rate of 20 L/min. The mass spectrometer was first
operated in Q1MS mode to confirm detection of the parent
ion. It was then operated in MS/MS mode to look for the
product ions for the selected parent. The “compound
optimization” feature of the Quantum Tune Master soft-
Table 1. Continued
Compounda
Neutral
formula
Parent
mass
Collision
energy
(eV)
Glucosamine-1-
phosphate
C6H14NO8P 260 15
Glucosamine-6-
phosphate
C6H14NO8P 260 15
Thiamine C12H16N4OS 265 17
Deoxyguanosine C10H13N5O4 268 15
Inosine C10H12N4O5 269 14
Guanosine C10H13N5O5 284 33
Xanthosine C10H12N4O6 285 20
Glutathione-reduced C10H17N3O6S 308 19
dCMP C9H14N3O7P 308 16
dUMP C9H13N2O8P 309 11
Thymidine
monophosphate
C10H15N2O8P 323 17
CMP C9H14N3O8P 324 16
UMP C9H13N2O9P 325 12
cyclic-AMP C10H12N5O6P 330 26
dAMP C10H14N5O6P 332 21
Thiamine-phosphate C12H17N4O4PS 345 13
AMP C10H14N5O7P 348 21
dGMP C10H14N5O7P 348 36
Inosine
monophosphate
C10H13N4O8P 349 19
GMP C10H14N5O8P 364 19
Xanthosine-5-
phosphate
C10H13N4O9P 365 11
Riboflavin C17H20N4O6 377 24
S-adenosyl-
homocysteine
C14H20N6O5S 385 19
S-adenosyl-
methionine
C15H22N6O5S 399 13
Folate C19H19N7O6 442 16
DHF C19H21N7O6 444 30
THF C19H23N7O6 446 41
5-methyl-THF C20H25N7O6 460 19
Glutathione-
oxidized
C20H32N6O12S2 613 33
dCMP, 2=-deoxycytidine-5=-monophosphate; dUMP, 2=-deoxyuridine 5=-
phosphate; cyclic-AMP, adenosine-3=,5=-cyclic-monophosphate; dAM
phate; dGMP, 2=-deoxyguanosine-5=-monophosphate; DHF, 7,8-dihydro
drofolate. Isoleucine and leucine are not separated in the present LC-M
aCompounds are listed in the order of their molecular weight.
bThe preferred product was selected primarily to maximize signal-to-n
compounds that have same parent mass and retention time.
cN/A, not applicable as only a single major product is formed.
dRT, retention time. Typical run-to-run variability in RT is 0.3 min. In th
eThe LOD is defined as the lowest concentration at which the signal-to-
not available because of their poor stability.ware was used to construct graphs of product ion signal asa function of collision energy (CE) for each of the four
most-abundant product ions. These graphs were then
used to determine the optimized CE to produce each
product ion. These optimized CEs were then used to
conduct SRM monitoring for each product ion during an
LC-MS/MS run.
Optimization of LC-MS/MS Conditions
LC conditions were optimized for groups of 10 or more
ferred
ductb
Mass of
preferred
product
Masses of
other major
productsc
RTd
(minutes)
LODe
(ng/mL)
12NO4
 162 72, 84, 144 6.9 5
8NO2
 126 84, 98, 108 6.7 1
8N3
 122 81, 144 6.7 5
6N5O
 152 110, 135 26.2 5
5N4O
 137 110, 119 25.2 1
3N4O
 135 110, 152 25.3 5
5N4O2
 153 136 27.0 1
8NO3S
 162 76, 84 7.8, 10.5 10
6N3O
 112 81 7.8 5
5O
 81 53 23.6 10
5O
 81 53, 127 27 5
6N3O
 112 95 7.8 0.5
5O2
 97 69, 113 16.2 10
6N5
 136 119, 312 26.5 1
6N5
 136 81 18.0 5
8N3
 122 81, 126, 224 7.6 5
6N5
 136 97, 119 12.4, 13.5 10
3N4O
 135 81, 110, 152 25.3 5
5N4O
 137 97, 119 23.8 10
6N5O
 152 110, 135 20.8 10
5O2
 97 153 25.2 10
H11N4O2
 243 145, 172, 198 34.5 5
6N5
 136 88, 134, 250 7.8 10
H12N5O3
 250 97, 102, 136 5.8 10
H11N6O2
 295 120, 176 33.5 1
8N5O
 178 136, 161 33.0 N/A
6NO
 120 166, 299 27.0 N/A
H17N6O2
 313 152, 180, 194 27.4 N/A
11N2O2S2
 231 355, 484 7.8 10
phosphate; CMP, cytidine-5=-monophosphate; UMP, uridine-5=-mono-
-deoxyadenosine-5=-monophosphate; AMP, adenosine-5=-monophos-
; THF, 5,6,7,8-tetrahydrofolate; 5-methyl-THF, 5-methyl-5,6,7,8-tetrahy-
method and therefore are listed together.
in certain cases, it also was selected to avoid interference from other
e of split peaks, the RT for the highest-intensity peak is marked in bold.
ratio is larger than 5. Information on DHF, THF, and 5-methyl-THF arePre
pro
C6H
C6H
C6H
C5H
C5H
C5H
C5H
C5H
C4H
C5H
C5H
C4H
C5H
C5H
C5H
C6H
C5H
C5H
C5H
C5H
C5H
C12
C5H
C10
C14
C7H
C7H
C15
C8H
mono
P, 2=
folate
S/MS
oise;
e cascompounds at a time, by incorporating multiple SRMs
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plored included column, the mobile phase composition
(solvent, pH), flow rate, and gradient. Columns tested
(all 250  2 mm from Phenomenex, Torrance, CA) were
Synergi 4 m Fusion-RP 80A (polar-embedded C18
with trimethyl siloxane endcapping), Synergi 4 m
Hydro-RP 80A (C18 with polar end-capping), Synergi 4
m Polar-RP 80A (ether-linked phenyl with polar end-
capping), and Luna 3 m C18(2) 100A (standard C18).
The organic solvents tested included methanol and
acetonitrile, with pH set by addition of formic acid,
acetic acid, ammonium formate, or ammonium acetate.
Overall performance for most of the 90 compounds (as
measured largely by signal-to-noise) was best for the
Fusion-RP column with water/methanol/0.1% formic
acid. In general, similar results were obtained with all of
the tested columns, with, for most compounds, metha-
nol/water/formic acid giving better signal-to-noise
than other mobile phases. The optimized LC conditions
used for all subsequent work were as follows: Solvent
A, water with 0.1% formic acid; Solvent B, methanol
with 0.1% formic acid; Fusion-RP column; column
equilibration time in 97% Solvent A/3% Solvent B  8
min before all injections; elution gradient, 0 min—3% B;
8 min—3% B; 38 min—95% B; 45 min—95% B; 47
min—3% B; 55 min—3% B.
After fixing the chromatography conditions, the re-
tention time for each compound was determined and an
LC-MS/MS method capable of detecting all 90 com-
pounds in a single run was developed. A constraint in
developing this method was that the Finnigan TSQ
Quantum Ultra triple-quadrupole mass spectrometer
software limits SRM scanning to a maximum of 64
different scans in any time period. Thus, it was not
possible to scan through the SRMs of all 90 compounds
throughout the entire 55-min LC-MS/MS run duration.
Instead, the run duration was divided into four differ-
ent time segments (0-12, 12-20, 20-30, and 30-55 min;
boundaries between these segments are indicated by
dashed lines on Figure 1), with the SRM scans con-
ducted within each time segment limited to those
corresponding to compounds eluting during that time
segment (e.g., for orotic acid, which elutes at 16 min, its
corresponding SRM scan of m/z 157 ¡ 68 is conducted
only during the second time segment, from 12 to 20
min). For compounds eluting at the boundaries be-
tween time segments, the SRM scan corresponding to
the compound is conducted in both time segments.
Challenges Associated With Compounds
of Identical Nominal Mass
Quadrupole mass spectrometry generally does not have
enough resolving power to distinguish compounds that
have identical nominal masses, even if they have dif-
ferent accurate masses. Nevertheless, in the LC-MS/MS
analysis, it often is possible to achieve high specificity
by the combination of characteristic SRM transitionsand chromatographic separation. Here, we briefly dis-
cuss specific challenges that we faced in developing the
present method with distinguishing compounds of
identical nominal mass. Isoleucine and leucine are
structural isomers that exhibit similar fragmentation
patterns and overlapping chromatography peaks; thus,
we could not distinguish them. Threonine and homo-
serine are isomers that co-elute chromatographically
but have certain distinctive product ions: 120 ¡ 57 for
threonine and 120 ¡ 44 for homoserine and are distin-
guished on that basis. We were similarly able to distin-
guish the following other compounds based on their
fragmentation: glucosamine-1-phosphate (260 ¡ 162)
versus glucoasmine-6-phosphate (260 ¡ 126) and re-
duced glutathione (308¡ 162) versus 2=-deoxycytidine-
5=-monophosphate (dCMP) (308 ¡ 112). Lysine and
glutamine form positive ions of m/z 147; however, they
are chromatographically well separated in the current
method and are distinguished on that basis. We were
similarly able to distinguish the following other com-
pounds chromatographically: ornithine versus aspar-
agine, p-aminobenzoic acid versus anthranilic acid,
glutamate versus acetyl-serine, arginine versus N-
acetyl-ornithine, biotin versus uridine, and adeno-
sine-5=-monophosphate versus 2=deoxyguanosine-5=-
monophosphate.
Method Validation for Purified Metabolites
The validity of our LC-MS/MS method was explored
with respect to compound stability, method reproduc-
ibility, limit of detection (LOD), and linearity. For
stability studies on purified compounds, metabolite
solution at a concentration of 500 ng/mL, with reser-
pine at 50 ng/mL as internal standard, in 50:50 metha-
Figure 1. Representative LC-MS/MS results for purified com-
pound standards (500 ng/mL). Dashed lines demarcate segments
of the LC-MS/MS run during which different sets of SRM scans
are performed. For simplicity, the figure shows results for only a
single SRM scan event in each time segment: in the first segment
SRM m/z 147 ¡ 84, which detects lysine and glutamine; in the
second segment SRM m/z 157 ¡ 68, which detects orotic acid; in
the third segment SRM m/z 269¡ 137, which detects inosine; and
in the fourth segment SRM m/z 377 ¡ 243, which detects ribofla-
vin.nol/water with 0.1% formic acid, was prepared. The
42 LU ET AL. J Am Soc Mass Spectrom 2006, 17, 37–50solution was split into four parts. One was analyzed
immediately. Others were stored separately at 80,
20, and 4 °C. These samples were analyzed after 1
week to evaluate the 1-week stability. Normalized sig-
nals, corresponding to the peak height of the metabolite
signal divided by the peak height of the internal stan-
dard signal, were compared for the various storage
conditions. In the present study, a compound is consid-
ered stable at a specified temperature if the normalized
signal after storage is within 15% of the original
normalized signal.
For reproducibility studies, mixed standard solu-
tions containing all 90 metabolites, each at 500 ng/mL,
and using reserpine at 50 ng/mL as internal standard,
were prepared and split into three parts and stored at
80 °C. The first sample was analyzed four times on
Day 1. The remaining two samples were analyzed on
Days 2 and 3, four times in each case.
To determine the method’s linearity and LOD, mix-
tures of the standard compounds at various concentra-
tions (2000, 1000, 500, 100, 50, 10, 5, 1, 0.5, and 0.1
ng/mL) were prepared and studied. For linearity anal-
ysis, the resulting data were analyzed by linear regres-
sion. For LOD analysis, the results were compared with
that of blank 50:50 methanol/water with 0.1% formic
acid. The LOD was defined as the lowest concentration
at which the signal-to-noise ratio, as defined by (C 
B)/M, where C is compound peak height, B is back-
ground height, and M is maximum peak to trough
height of the noise, was at least 5.
Determination of the Carbon Count
of Product Ions
To enable quantitative comparison of isotope-labeled
versus isotope-unlabeled cellular extracts based on 12C/
13C-peak ratios, it is necessary to know the number of
carbon atoms in parent ions and product ions. Although
the molecular structures of the parent ions are known,
those of the product ions generally are not known,
because collision-induced fragmentation/dissociation
can be complicated, especially when internal rearrange-
ment is involved. We used several complementary
approaches to dissect the structure of the product ions.
First, we referred to available literature, which is espe-
cially comprehensive with respect to amino acid frag-
mentation [27–31] and contains information on the
fragmentation of numerous other metabolites [32–37].
Second, when literature regarding fragmentation of
specific metabolites of interest was not available, we
inferred the likely fragment lost based on the change in
molecular weight, using the following heuristic: 17 
NH3; 18  H2O; 42  CH2CO; 43  HNCO; 46  H2O
 CO. Finally, when possible (i.e., for the 36 com-
pounds listed in Table 2), the number of the carbon
atoms in the product ion was determined using 13C-
labeled metabolite produced in bacteria fed 13C-glu-
cose.Bacterial Strain and Culture Conditions
Salmonella enterica LT2 strain TR10000 was used for all
biological experiments. The cells were grown in M9
media containing a final concentration of 10 mM of
NH4Cl, 5.6 mM of glucose (unlabeled or
13C-labeled, as
indicated), 0.1 mM of CaCl2, 2 mM of MgSO4, 48 mM of
Na2HPO4, 22 of mM KH2PO4, and 8.6 mM of NaCl.
Exponential-phase cultures were produced by grow-
ing bacteria to saturation in 5 mL of the M9 media on a
roller at 37 °C for approximately 14 h and then diluting
the saturated culture tenfold into 50 mL of M9 media in
a 250-mL flask. This diluted culture was then grown on
a shaker at 37 °C until in exponential phase, i.e., optical
density at 650 nm (OD650) of0.35 and then the extracts
were prepared as described in the following para-
graphs. For producing uniformly 13C-labeled extracts,
cultures were grown to saturation at least twice in
13C-glucose to ensure nearly complete turnover of all
carbon atoms before initiating the final culture, which
was collected in exponential phase (OD650  0.35).
Stationary-phase cultures were produced by allowing
diluted cultures to grow on a shaker at 37 °C for
approximately 28 h, resulting in OD650  0.55. The
growth of the stationary-phase cultures was limited by
availability of usable carbon, as indicated by the fact
that cultures grown in double the amount of glucose
reached a substantially higher OD650 before entering
stationary phase.
Metabolite Extraction
Bacteria were separated from media by centrifugation
for 6 min at 3000  g and 23 °C. Immediately on
completion of spin, the supernatant was discarded and
300 L of 80:20 methanol/water with 50 ng/mL of
reserpine as internal standard at dry-ice temperature
(75 °C) was added to the pellet and vortexed to mix.
The cell suspension was then allowed to sit on dry ice
for 15 min. At the end of the 15 min, the sample was
spun in a microcentrifuge at 13,200 rpm for 5 min at 4
°C. The soluble extract was then removed and placed on
dry ice and the pellet was resuspended in 200 L of the
same 80:20 methanol/water solution by vortexing. This
suspension was then placed on dry ice for 15 min before
being again centrifuged to yield a second clear extract,
which was combined with the first extract. The pellet
was again resuspended in the same 80:20 methanol/
water solution by vortexing and the resulting suspen-
sion was sonicated in an ice bath for 15 min using a
FS30H Ultrasonic Cleaner (Fisher Scientific) with a
power of 100 W at 42 kHz (note: very similar results
also were obtained without sonication). Once the 15
min was complete, the sample was again spun down
and the resulting extract was combined with the initial
two extracts.
To explore the efficiency of the foregoing serial
extraction procedure, the pellet of cellular material
collected after the third extraction step by centrifuga-
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with a variety of different solvents. Each solvent was
tested in an independent tube containing a pellet of the
already extracted cellular material. The solvents were as
follows: (1) 80:20 methanol/water (“methanol”), (2)
80:20 ethanol/water (“ethanol”), (3) 80:20 methanol/
water  1% formic acid (“acidic methanol”), (4) 80:20
methanol/water  1% ammonium hydroxide (“basic
methanol”), and (5) 67:33 chloroform/methanol (“chlo-
roform/methanol”). After the 15-min extraction period,
the samples were spun in the microcentrifuge to yield
clear extracts. Before LC-MS/MS analysis, the “basic
methanol” extract was neutralized by addition of for-
mic acid and the “chloroform/methanol” extract was
dried and resuspended in 80:20 methanol/water. The
resulting solutions were analyzed as usual by LC-
MS/MS with SRMs designed to detect 27 of the 36
Table 2. LC-MS/MS results for 36 compounds that can be detec
Compound
Parent
mass
CE
(eV)
Glycine 76 16
Putrescine 89 11
Alanine 90 11
Proline 116 11
Valine 118 11
Threonine 120 30
Isoleucine/Leucine 132 11
Aspartic Acid 134 15
Hypoxanthine 137 19
Anthranilic acid 138 20
Glutamine 147 15
Glutamate 148 15
O-Acetyl-L-serine 148 12
Methionine 150 10
Phenylalanine 166 28
Arginine 175 14
Citrulline 176 12
Tyrosine 182 14
Tryptophan 205 16
Pantothenic acid 220 20
Glucosamine-6-phosphate 260 15
Deoxyguanosine 268 15
Inosine 269 14
Xanthosine 285 20
Glutathione-reduced 308 19
dCMP 308 16
Thymidine monophosphate 323 17
CMP 324 16
UMP 325 12
Cyclic AMP 330 26
dAMP 332 21
AMP 348 21
Inosine monophosphate 349 19
Riboflavin 377 24
S-Adenosyl-methionine 399 13
Glutathione-oxidized 613 33
dCMP, 2=-deoxycytidine-5=-monophosphate; CMP, cytidine-5=-monoph
phate; dAMP, 2’-deoxyadenosine-5=- monophosphate.
aThe term 12C-noise refers to the 12C-signal for cells grown in 13C-gl
unlabeled glucose.
See Table 1 for abbreviation meanings.compounds listed in Table 2 (omitted for suboptimalsignal-to-noise and/or historical reasons: glycine,
acetyl-serine, phenylalanine, arginine, tyrosine, glu-
cosamine-6-phosphate, dCMP, thymidine monophos-
phate, UMP.
Method Development for Bacterial Extracts
The LC-MS/MS method described previously, having
been validated with respect to its performance for
purified metabolites, was tested on bacterial cell ex-
tracts (exponential phase). Extracts from bacteria grown
both in unlabeled (12C-) and (with appropriate modifi-
cation of the SRMs to account for the molecular weight
increase) 13C-glucose were tested. Approximately 50%
of the metabolites failed to give a specific and repro-
ducible signal from the bacterial cell extracts, indicating
that many of these metabolites are present in the
ithout interference from S. enterica bacterial extract
roduct
mass
12C-signal
(noisea)
13C-signal
(noisea)
30 4.98E3 (5.7%) 9.64E3 (0.1%)
72 6.77E5 (0.2%) 8.33E5 (0.1%)
44 1.00E6 (0.4%) 1.36E6 (0.1%)
70 1.66E5 (0.4%) 2.10E5 (0.3%)
55 2.22E5 (0.1%) 2.59E5 (0.1%)
57 2.42E3 (1.7%) 3.97E3 (0.3%)
86 2.20E5 (1.3%) 3.08E5 (0.1%)
74 3.37E4 (2.6%) 3.20E4 (0.1%)
110 1.80E4 (0.8%) 2.55E4 (2.6%)
92 2.06E3 (22.3%) 1.07E3 (3.7%)
84 1.37E6 (0.1%) 1.92E6 (0.1%)
84 9.28E6 (0.1%) 1.07E7 (0.1%)
106 5.00E3 (6.7%) 9.57E3 (3.2%)
133 3.19E4 (1.3%) 3.95E4 (1.5%)
103 3.10E4 (0.8%) 3.48E4 (2.2%)
60 1.16E4 (0.1%) 6.21E3 (0.2%)
159 3.21E5 (0.4%) 2.29E5 (0.3%)
136 7.36E4 (1.8%) 8.34E4 (0.1%)
146 3.31E5 (0.7%) 3.67E5 (0.1%)
90 1.47E4 (0.2%) 2.00E4 (1.4%)
126 4.53E3 (6.0%) 6.33E3 (0.3%)
152 9.40E3 (9.2%) 1.05E4 (0.2%)
137 1.33E5 (0.6%) 1.07E5 (0.1%)
153 8.79E3 (1.3%) 1.09E4 (0.1%)
162 3.29E6 (0.1%) 3.26E6 (0.1%)
112 5.86E4 (0.1%) 7.93E4 (0.1%)
81 3.26E4 (0.5%) 4.08E4 (0.4%)
112 1.23E5 (0.1%) 1.34E5 (0.1%)
97 4.66E4 (0.6%) 5.39E4 (0.1%)
136 2.21E4 (2.0%) 3.15E4 (0.1%)
136 2.20E4 (0.2%) 2.66E4 (0.1%)
136 7.90E5 (0.1%) 9.13E5 (0.1%)
137 1.34E5 (0.1%) 1.71E5 (0.1%)
243 1.78E5 (0.1%) 2.58E5 (0.1%)
250 1.35E5 (0.1%) 7.62E4 (1.6%)
231 7.92E4 (0.1%) 8.03E4 (0.1%)
ate; UMP, uridine-5=-monophosphate; AMP, adenosine-5=-monophos-
; the term 13C-noise is analogously the 13C-signal for cells grown inted w
P
osph
ucosebacterial extracts in low amounts. For a smaller number
44 LU ET AL. J Am Soc Mass Spectrom 2006, 17, 37–50of metabolites, interfering peaks arising from other
biological materials were present either in 12C- or in
13C-grown bacterial extracts and precluded reliable
analysis. Therefore, analysis of bacterial extracts fo-
cused on 36 compounds for which both 12C- and
13C-grown cells showed readily detectable peaks with-
out interferences. A method involving 72 SRMs corre-
sponding to the 12C- and 13C-forms of these 36 metab-
olites (divided as described previously into segments)
was developed accordingly.
Method Validation for Bacterial Extracts
The validity of the bacterial extract analysis method
was explored with respect to peak identity and quanti-
tative reproducibility. Confirmation that an observed
peak in a biological extract corresponded to a particular
metabolite was obtained by spiking a 13C-labeled bio-
logical extract with 100 ng/mL of purified metabolite
(not isotope labeled) and checking that the purified
standard coeluted with the peak from the biological
extract. In addition, it was confirmed that the height of
the 12C-peak from a culture grown in unlabeled glucose
(12C-culture) was much greater than that of the 12C-
peak from a culture grown in 13C-labeled glucose
(13C-culture), and likewise for the 13C-peak. Finally, it
was confirmed that the height of the 12C-peak from a
12C-culture was comparable with that of the 13C-peak
from an identical 13C-culture.
The reproducibility of 12C/13C-ratio measurements
in mixtures of 12C- and 13C-extracts was determined by
repeatedly growing exponential-phase 12C-cultures and
13C-cultures, preparing the corresponding extracts, and
mixing these extracts in the ratio of 10 parts 12C-extract
to 1 part 13C-extract. The resulting extract mixtures
were then analyzed by LC-MS/MS multiple times, to
enable determination of both within-sample and be-
tween-sample ratio measurement reproducibility.
Comparison of the Metabolomes of Exponential
versus Stationary-Phase Bacteria
Both exponential- and stationary-phase cultures were
grown as described above. The bacterial doubling time
during exponential phase was approximately 65 min
(except in a single case where the doubling time was
approximately 2 h and the culture was accordingly
excluded from analysis). Extracts were then prepared,
mixed with one-tenth their volume of exponential-
phase control extract (13C-labeled), and analyzed to
yield the 12C/13C-ratio. Certain extract samples were
analyzed multiple times by LC-MS/MS, in which case
the mean ratio was taken as the value for that extract.
The ratios were corrected for the density of the cultures
from which they were derived, by normalizing to the
target exponential density of OD650  0.35 (i.e., if the
observed OD in the 12C-culture was 0.32, then the
observed ratio was multiplied by 0.35/0.32; all expo-nential-phase cultures were collected at an OD between
0.3 and 0.35 and all stationary-phase cultures were
collected at an OD between 0.51 and 0.65). The loga-
rithm (base 2) of the normalized 12C/13C-ratio for each
extract mix was then taken, and the mean log ratio was
determined for the exponential-phase (n  4) and the
stationary-phase (n  4) cultures. The mean log ratio
was then compared between the exponential- and sta-
tionary-phase cultures for each metabolite using a two-
tailed student’s t-test.
Absolute Quantitation of Bacterial
Glutamate and Glutamine
Exponential phase, fully 13C-labeled S. enterica (50 mL
of culture volume at OD650 0.32) were pelleted by
centrifugation and their metabolites were serially ex-
tracted into a total volume of 700 L as described earlier
in the text. An aliquot of 50 L of this extract was then
mixed with an equal volume of unlabeled metabolite
standard mix containing 200 ng/mL of each of gluta-
mate and glutamine, to yield a final unlabeled gluta-
mate and glutamine concentration in the mixture of 100
ng/mL. Analysis of this sample by LC-MS/MS yielded
the following peak heights: 13C-glutamate, 3.1  107;
12C-glutamate, 9.2  104; 13C-glutamine, 7.5  106;
12C-glutamine, 4.5  105. The absolute 13C-glutamate
concentration in the sample was calculated as follows:
[13C-glutamate]
100 ng ⁄ mL
13C-peak height
12C-standard height
 34 g ⁄ mL
Thus, the 50-mL culture contained a total glutamate
content of 34 g/mL  0.7 mL extraction volume 
twofold dilution factor  48 g and, analogously, a
total glutamine content of 2.4 g. Drying and weighing
of an equivalent 50 mL of S. enterica culture (of identical
OD) yielded a cell dry weight (CDW) of 8 mg. Thus, the
cellular glutamate content is 6 g/mg CDW, which is
equivalent to 40 nmol/mg CDW; analogously, the cel-
lular glutamine content is 2 nmol/mg CDW.
Results and Discussion
Assay Development and Validation
for Purified Metabolites
The current assay focuses on nitrogen-containing com-
pounds involved in core metabolic or biosynthetic
processes for which purified forms of the compounds
are commercially available. It involves separation of the
compounds using typical reverse-phase chromatogra-
phy, followed by detection of the compounds using
triple-quadrupole mass spectrometry in SRM mode.
The product ions to monitor by SRM were selected
based on the MS/MS fragmentation pattern of each
metabolite, which was determined using the commer-
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resentative LC-MS/MS chromatograms for five differ-
ent compound standards, with multiple different SRM
scan events superimposed on a single figure. Table 1
provides the MS/MS fragmentation results (positive-
ion mode) and LC retention times for all 90 studied
metabolites. Each parent ion gives a number of product
ions and the preferred product was selected to give the
best signal-to-noise in the LC-MS/MS analysis, while
also avoiding, when relevant, interference from any
other compounds of the same parent mass and similar
LC retention time. Notably, the chromatography por-
tion of the current assay is imperfect, in that many
compounds elute closely packed together between 5-
and 8-min retention time. In addition, a few compounds
show peak splitting. Nevertheless, as described in the
following paragraphs, the combined power of LC and
MS/MS enables sensitive and specific detection of most
metabolites.
Before using the assay, the stability of the 90 metab-
olites being studied was determined. Purified metabo-
lites were stored for 1 week at 80, 20, or 4 °C in
acidic (pH 3.8) methanol/water solution. Of the 90
compounds in Table 1, 87 were stable during the
1-week test (final peak height  initial peak height 
15%). The three unstable compounds were dihydrofo-
late, tetrahydrofolate (THF), and 5-methyltetrahydrofo-
late (5-methyl-THF), each of which showed a half-life of
less than 1 week at 4 °C and was accordingly omitted
from all additional analyses.
The LOD of the remaining 87 stable metabolites was
determined by analyzing the signal-to-noise at different
concentrations. The results are summarized in Table 1
and the distribution of LOD can be seen in Figure 2a.
Over 85% of the compounds show an LOD of 10 ng/mL
or lower, indicating the sensitivity of the present
method. The linearity of the assay also was explored, in
the range from each metabolite’s LOD up to 100 times
the LOD (stopping at a maximum concentration of 2
g/mL for those metabolites with a LOD 20 ng/mL).
Exemplary data, corresponding to glutamine, are
shown in Figure 2b. For all but one compound, folate,
the assay yields an R2  0.95 for linear regression of
signal versus metabolite concentration, with R2  0.98
for more than 90% of the compounds and R2  0.99 for
more than 80% of the compounds. Thus, the assay is
linear over two orders of magnitude for most of the
compounds.
Reproducibility of the assay for purified metabolites
was evaluated by measuring the relative standard de-
viation (RSD) between runs, both within and between
days, for a mixture containing all 87 of the studied
stable metabolites, at a concentration of 500 ng/mL
each, with the signal for each test compound normal-
ized to the signal for the internal standard reserpine.
Intra-day reproducibility was determined by conduct-
ing four repeat runs on each of 3 days. The mean
intra-day RSD was 6% and was less than 15% for all of
the compounds on at least 2 of the 3 test days, with 95%of the compounds having an RSD  15% on all 3 test
days (exceptions: urea, xanthine, allantoin, and de-
oxyuridine, which all were nevertheless associated with
an RSD 25% on all test days). Regarding the inter-day
reproducibility, the mean RSD across all 12 runs di-
vided over the 3 different days was 9%, with 97% of the
compounds showing an RSD  15% (exceptions, urea,
xanthine, and oxidized glutathione, which all were
nevertheless associated with an RSD  25%). Thus, for
most compounds, the reproducibility of analysis using
the current method is comparable with that typically
achieved with SRM methods focusing on only one or a
few analytes.
Extraction of Metabolites from S. Enterica
The foregoing method, having been validated with
respect to its performance on purified metabolites, was
used to study the extraction of metabolites from the
bacterium S. enterica. Extracts were produced by cen-
trifugation of S. enterica liquid culture to yield a con-
centrated cell pellet, followed by addition of cold (75
°C) methanol/water mixture to the cell pellet to quench
metabolism and extract metabolites. The cold metha-
nol/water likely releases metabolites in part through
membrane disruption induced by formation of micro-
scopic ice crystals. Three rounds of serial extraction
with methanol/water, the first two at 75 °C and the
final one at 4 °C, were used to attempt to release most
cellular metabolites while avoiding conditions likely to
cause metabolite degradation such as heat, acid, or
Figure 2. LC-MS/MS method performance for purified metabo-
lites. (a) Histogram of the distribution of the LOD for the 87 stable,
purified compounds listed in Table 1. (b) Representative linearity
test results for glutamine.base [14].
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procedure in releasing metabolites was explored by
re-extracting the residual cellular material remaining
after the three rounds of serial extraction. For re-
extraction, a variety of different solvent systems were
tested: methanol, ethanol, acidic methanol, basic meth-
anol, and chloroform/methanol. Of the compounds
found in detectable amounts in the initial serial extracts,
70% were not detectable after re-extraction with any of
the tested solvents. The concentrations of the com-
pounds that were detectable after re-extraction are
shown in Figure 3, plotted versus the concentration of
the same compound found in the initial extract. For all
re-extraction solvents, all compounds were found in
lower concentrations on re-extraction than initial extrac-
tion, with only riboflavin and putrescine found on
re-extraction at concentrations of more than 10% of
those present in the initial extract. Thus, our three-
round serial extraction procedure seems to release most
metabolites effectively.
Assay Development and Validation
for Quantitative Comparison of Biological Extracts
For quantitative analysis of biological extracts, we
Figure 3. Efficiency of metabolite extraction. S. enterica were
serially extracted three times with 80:20 methanol/water. The
residual cellular material was then re-extracted with different
solvents as indicated in the figure and described in greater detail
in the Experimental section. Of the metabolites detected in the
initial serial extracts, 70% were not detected with any method of
re-extraction and are not included in the figure. For those metab-
olites detected with at least one method of re-extraction, the
concentration of that metabolite in the initial extract (X-axis) is
plotted versus the concentration obtained on re-extraction (Y-
axis). The solid line is the line of unity. The finding that all points
fall to the right of this line indicates that every metabolite was
more concentrated in the initial sample than in any sample
produced by re-extraction. The dashed line is the line of 10%.
Points falling to the right of this line indicate that the initial sample
contained at least tenfold more concentrated metabolite than the
sample produced by re-extraction.aimed to develop a method involving measurement ofthe ratios of unlabeled versus isotope-labeled metabo-
lites, because this approach has the potential to control
for ion suppression and other effects that could other-
wise cause spurious findings in a mixture as complex as
a cellular extract. To generate isotope-labeled forms of
metabolites, S. enterica was grown in uniformly 13C-
labeled glucose (in the absence of any other carbon
sources), which by necessity must result, after numer-
ous rounds of cell divisions, in uniform 13C-labeling of
all intracellular metabolites.
To determine which metabolites could potentially be
measured reliably from S. enterica extracts using this
approach, we searched for metabolites that met the
following criteria: (1) the peak corresponding to the
12C-metabolite (the 12C-peak) is much larger for cells
grown in unlabeled (essentially 12C-) glucose than for
cells grown in 13C-glucose, (2) the 13C-peak is much
larger for cells grown in 13C-glucose than for cells
grown in unlabeled glucose and is comparable in mag-
nitude with the 12C-peak for cells grown in unlabeled
glucose, and (3) the 13C-peak overlays perfectly with the
12C-peak when extract from cells grown in 13C-glucose
are spiked with purified unlabeled metabolite. In Fig-
ures 4 and 5, we show representative results using the
amino acid glutamate as an example. In total, 36 me-
tabolites met the foregoing criteria and are listed in
Table 2. The 12C-signal in Table 2 refers to the 12C-peak
observed for cells grown in unlabeled glucose, and the
12C-noise (expressed as a percent of the 12C-signal)
refers to the 12C-peak for cells grown in 13C-glucose.
The 13C-signal and noise are defined analogously.
Based on the foregoing results, we developed an
LC-MS/MS method, which involves 72 SRMs, corre-
sponding to the uniformly 12C- and 13C-forms of each of
the 36 metabolites listed in Table 2. To determine the
metabolite profile of a test culture, we grow the test
culture using unlabeled media of our choosing and mix
the resulting extract with 13C-extract produced from
cells grown under fixed conditions, with the 13C-metab-
olites serving as internal standards for the 12C-metabo-
lites from the test culture. The concentration of test
metabolite is then reported as the ratio of the 12C-signal
to the 13C-signal in the extract mix. Theoretically, in this
manner, we can compare any number of cultures grown
under different conditions by mixing an extract from
each of these unlabeled cultures with a fixed internal
standard 13C-extract.
To determine the reproducibility of LC-MS/MS mea-
surement using this 12C/13C-metabolite ratio approach,
we analyzed two different extract mixtures repeatedly
(n  3 runs for each of two extract mixtures). The mean
RSD for repeated measurement of the same sample was
12% and was strongly influenced by a few metabolites
associated with larger RSDs, with the median RSD only
7%. The largest RSDs were associated with O-acetyl-l-
serine (37%) and glucosamine-6-phosphate (40%), both
compounds with relatively poor signal-to-noise in S.
enterica extracts (Table 2). Overall, the reproducibility of
analysis of the mixed extract samples generally was in
other
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LC-MS/MS methods.
Having determined that ratio-based analysis of any
particular sample is reasonably reproducible, we ex-
plored the reproducibility of our overall process, start-
ing with cell culture and proceeding through to LC-
MS/MS analysis, using mixed extracts produced from
four different sets of exponential-phase 12C- and 13C-
Figure 4. Measurement of 12C- versus 13C-glu
versus 13C-labeled glucose. Chromatograms s
glutamate SRM signal (b) for extract from S. ent
(right). Note that the absolute magnitude of the
bottom right panels greatly exceeds that in the
Figure 5. Spiking of 13C-labeled S. enterica extract with unlabeled
purified glutamate (100 ng/mL). The top chromatogram shows
the 12C-glutamate SRM signal and the bottom shows the 13C-
glutamate SRM signal.cultures grown on 4 different days. The variability
associated with cell culture and extraction was substan-
tial, resulting in a mean RSD between theoretically
identical mixed extracts of 39%. These results highlight
the challenges in growing and extracting bacteria in a
manner that produces a consistent metabolome extract.
Work to address these challenges is ongoing.
Metabolome Differences between Growing
and Carbon-Starved S. enterica
Despite the observed culture-to-culture variability with
fixed cell growth conditions, we were curious whether
changes in the S. enterica metabolome associated with
biological manipulations could be detected by our ratio-
based method. Therefore, we compared exponentially
growing S. enterica with S. enterica driven into station-
ary phase by carbon starvation, using the same 13C-
extract as the internal control for both test conditions.
To mitigate the effects of culture-to-culture variability,
four independent sets of exponential- and stationary-
phase cultures were compared. Following the tradition
of analysis of genome-wide expression analysis using
DNA microarrays, we report our results as the log
(concentration in the stationary-phase cells/concentra-
tion in the exponential-phase cells; Figure 6). The sta-
tistical significance of the observed metabolite concen-
tration changes can be assessed using t-test to compare
the log values from the two different culture conditions,
with 21 of the 36 metabolites investigated showing a
statistically significant change in concentration between
ate in extracts of bacteria grown in unlabeled
the 12C-glutamate SRM signal (a) and 13C-
rown in unlabeled glucose (left) or 13C-glucose
al (maximum Y-axis value) in the top left and
panels.tam
how
erica g
signexponential and stationary phase as indicated by p 
48 LU ET AL. J Am Soc Mass Spectrom 2006, 17, 37–500.05. Because we are making 36 statistical comparisons,
some of the results at p  0.05 are likely because of
chance alone; nevertheless, the expected number of
false discoveries is less than 2 of the 21 discoveries
made. Thus, despite the culture-to-culture variability
we observe, we are able to identify numerous changes
in metabolome composition associated with bacterial
entry into the stationary phase.
The metabolite profile observed in the stationary-
phase cells is notable in several respects. Many more
metabolites are decreased than increased in concentra-
tion in the stationary phase, as might be expected for
less metabolically active cells. A few metabolites, how-
ever, are increased in the stationary phase, including
glutathione (both oxidized and reduced), which may
provide protection for the stationary cells against redox
stress [38]. In terms of metabolites that decreased in
concentration, the most striking result is for the amino
acid valine, which decreased approximately 60-fold,
with alanine also markedly decreased. To our knowl-
edge, large decreases in the concentrations of these
amino acids in bacterial stationary phase have not been
reported previously. Alanine and valine are both prod-
ucts of pyruvate; accordingly, it will be interesting in
future studies to determine the concentration of pyru-
vate in stationary-phase cells. Other metabolites show-
ing marked decreases during stationary phase include
various metabolic intermediates and glutamine. Addi-
tional experiments involving stationary phase in-
duced by various different stimuli (e.g., other types of
Figure 6. Metabolome differences between
(stationary culture) S. enterica. Data represent th
exponential-phase cultures.nutrient starvation) and including holistic analysis ofcellular transcriptional events will be required to
attach greater biological meaning to these prelimi-
nary findings.
Methodology for Absolute Quantitation
of Cellular Metabolite Content
An isotope-ratio-based approach also can be used for
absolute quantitation of cellular metabolite content us-
ing data of the type shown in Figure 5 [23]. The absolute
concentration of 13C-cellular metabolite in a test sample
is determined based on the relative size of the 13C-peak
corresponding to the extracted cellular metabolite ver-
sus the 12C-peak corresponding to a known concentra-
tion of purified standard. Because the present LC-
MS/MS method is linear, the absolute 13C-metabolite
concentration, [13C-cellular metabolite], can be calcu-
lated as follows:
[13C-cellular metabolite]
[12C-standard]
13C-peak height
12C-standard height
The absolute 13C-metabolite concentration multi-
plied by the extract volume and the dilution factor
introduced when adding the 12C-standard determines
the absolute metabolite yield from the collected cells.
Dividing by the dry weight of the collected cells then
yields the metabolite yield per CDW. In this manner,
ing (exponential culture) and carbon-starved
rage of four independent stationary-phase andgrow
e avewe have determined that our S. enteric extracts contain
49J Am Soc Mass Spectrom 2006, 17, 37–50 QUANTITATION OF N-CONTAINING METABOLITES40 nmol of glutamate and 2 nmol of glutamine per
milligram of CDW. We focus on absolute quantitation
of these two metabolites because their absolute concen-
trations in S. enterica have previously been determined
carefully by alternative means [12]. Our results are
consistent with the prior literature, falling in the middle
of the range of the glutamine and glutamate quantities
previously reported in various strains of S. enterica
under different growth conditions [12].
Conclusion
LC-MS/MS with ESI is well recognized as a powerful
means of characterizing chemical mixtures. Here, we
show that triple-quadrupole LC-MS/MS can be used to
quantitate numerous known metabolites in parallel, by
scanning repeatedly through different SRM events.
Such an LC-MS/MS approach works effectively for 90
purified metabolites and in theory still could be ex-
panded to a greater number without compromising
quantitative performance.
When applying LC-MS/MS to quantify components
of a complicated sample, use of isotope-labeled internal
standard corrects for many potential sources of artifact,
most importantly those arising from ion suppression
caused by coeluting compounds. Consistent with pre-
vious reports that involved a smaller number of metab-
olites [20–23], here, we find that isotope-labeled stan-
dard for cellular metabolites can be produced by
extracting cells grown in uniformly 13C-labeled glucose.
The absolute concentration of metabolites in this 13C-
extract can be determined by spiking the extract with
known concentrations of purified unlabeled metabolite
standards [23]. Mixing this 13C-internal standard extract
into unlabeled test extract enables isotope-ratio-based
metabolite quantitation, with the method described
here involving 72 SRM scans to measure the 12C- and
13C-forms of each of 36 metabolites. This 72-SRM
method provides a useful tool for exploring the effect of
cell growth conditions on intracellular metabolite con-
centrations. For example, we find statistically signifi-
cant changes in the concentrations of 21 metabolites
associated with bacterial entry into the stationary
phase. Many of the metabolite concentration changes
reflect new biological discoveries that may facilitate
efforts toward a complete understanding of cellular
physiology.
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